-
G412595-5mgInformationGusacitinib (ASN-002) is an orally active and potent dual inhibitor of spleen tyrosine kinase (SYK) and janus kinase (JAK) with IC50 of 5-46 nM. Gusacitinib has anti-cancer activity.
-
-
-
-
-
-
-
G288949-10mgSelective EP4receptor competitive antagonist.
-
G288949-1mgSelective EP4receptor competitive antagonist.
-
G288949-250mgSelective EP4receptor competitive antagonist.
-
G288949-25mgSelective EP4receptor competitive antagonist.
-
G288949-50mgSelective EP4receptor competitive antagonist.